📰 Arthur Oubrie News
Arthur Oubrie News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Arthur Oubrie. Real-time updates on events, politics, business and more.
July 15, 2022
Therapeutics developer Lead Pharmaceutical (Oss, Netherlands) and French medicinal chemistry and custom synthesis company Oxeltis, have been awarded an €800K ($842K) grant from EUREKA Eurostars for a three year project aimed at developing a first-in-class small molecule therapy for diffuse large B-cell lymphoma (DLBCL). Click to read more...
June 9, 2022
Dutch firm Lead Pharma and French company Oxeltis have been awarded an €800K grant from the 37-nation EUREKA intergovernmental network’s Euro...
June 8, 2022
Grant will fund three-year EPIGENEXT joint project aimed at developing first-in-class therapy for diffuse large B-cell lymphoma  Oss, the Netherlands and Montpellier, France, June 8, 2022 – Lead Pharma, a privately held pharmaceutical company designing and developing innovative therapies for the treatment of immune-...